Dr. Jeyanthi Kunadhasan, WarRoom/DailyClout Researcher, Follows Up with the Therapeutic Goods Administration Re-Emphasizing That Pfizer Had More Vaccinated Deaths Than Placebo Deaths in Its COVID Vaccine Clinical Trial
Following up on her unanswered April 6, 2024, letter to Professor Tony Lawler, Deputy Secretary of Australia’s Therapeutic Goods Administration (TGA), Dr. Jeyanthi Kunadhasan, an anaesthetist and perioperative physician in Australia and Treasurer of the Australian Medical Professionals’ Society, wrote to him again on May 17, 2024. She again expressed concern about the vaccinated deaths in Pfizer’s C4591001 COVID-19 vaccine clinical trial. Dr. Kunadhasan provided multiple examples demonstrating that Pfizer did not disclose all vaccinated deaths during the trial to the Food and Drug Administration (FDA) when submitting data for its emergency use authorization (EUA) application. She shows that Pfizer’s failure to report all of the deaths led to the FDA granting EUA based on incomplete data, which falsely showed more deaths in its placebo group. Despite the seriousness of these findings, Dr. Lawler’s lack of response to her April 6th letter suggests both TGA and he are unconcerned with Pfizer’s falsified data.
On March 27, 2024, Professor Lawler responded to Dr. Kunadhasan’s earlier letter saying, “It is reassuring to note that, in this case, none of the deaths in the trial have been attributed to the vaccine and the initial conclusions remain valid. The accumulating published evidence over time continues to support the significant public health benefit of the safety and efficacy of mRNA vaccines, as well as an overwhelmingly favourable risk/benefit ratio.” His response indicated a reluctance to acknowledge the accurate Pfizer trial data or to ensure that Australians are informed of it.
In her latest letter, Dr. Kunadhasan details 10 vaccinated deaths that occurred during the Pfizer clinical trial. In each instance, the trial investigator concluded that “…there was no reasonable possibility that the [cause of death] was related to the study intervention, concomitant medications, or clinical trial procedures…” The investigator often reaches that conclusion in the absence of autopsy results, so one wonders how he or she can be so certain the subjects’ deaths were not related to Pfizer’s vaccine, other medications, or trial procedures. In each of the 10 cases highlighted for Professor Lawler, Dr. Kunadhasan challenges Professor Lawler to clarify the evidentiary basis upon which the TGA relied to agree with such statements.
The vaccinated arm of Pfizer’s clinical trial had 21 deaths. Autopsies were only conducted for three of those subjects, with results made available for just one. Ten of these 21 deaths were people found dead or who had suffered sudden adult death (SAD), making the lack of autopsies especially concerning given Pfizer investigators’ conclusions that the deaths were unrelated to its novel drug.
Dr. Kunadhasan concludes her May 17th letter by stating, “Based on the cases I have highlighted, I find it difficult to accept the statement in your letter dated 27th March 2024, ‘It is reassuring to note that, in this case/ none of the deaths in the trial have been attributed to the vaccine and the initial conclusions remain valid.’ I hope you can appreciate that I am continuing to highlight the substantial efficacy and safety issues in this trial despite reputational, regulatory, financial, and personal risk to myself. I am doing so because I want to continue to uphold my oath and code of conduct.”
DailyClout commends Dr. Kunadhasan for her dedication to truth and transparency. Her most recent letter is below.
Pre-Order The Pfizer Papers Book.
Subscribe to DailyClout so you never miss an update!
One of our country’s most important freedoms is that of free speech.
Agree with this essay? Disagree? Join the debate by writing to DailyClout HERE.